Kendall Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.76M Sell
3,710
-200
-5% -$101K 0.36% 72
2025
Q4
$1.83M Sell
3,910
-240
-6% -$111K 0.38% 61
2025
Q3
$1.77M Sell
4,150
-15
-0.4% -$5.81K 0.4% 60
2025
Q2
$1.6M Sell
4,165
-185
-4% -$66.7K 0.42% 61
2025
Q1
$1.5M Sell
4,350
-110
-2% -$35.4K 0.44% 62
2024
Q4
$1.34M Sell
4,460
-195
-4% -$68.1K 0.39% 69
2024
Q3
$1.89M Sell
4,655
-70
-1% -$25.6K 0.58% 50
2024
Q2
$1.52M Sell
4,725
-25
-0.5% -$8.12K 0.51% 61
2024
Q1
$1.58M Sell
4,750
-265
-5% -$81K 0.55% 60
2023
Q4
$1.36M Sell
5,015
-50
-1% -$12.4K 0.53% 60
2023
Q3
$1.25M Sell
5,065
-665
-12% -$182K 0.55% 60
2023
Q2
$1.74M Sell
5,730
-70
-1% -$19.5K 0.76% 39
2023
Q1
$1.53M Sell
5,800
-446
-7% -$113K 0.73% 39
2022
Q4
$1.5M Sell
6,246
-395
-6% -$88.5K 0.76% 37
2022
Q3
$1.22M Sell
6,641
-157
-2% -$31.3K 0.71% 46
2022
Q2
$1.14M Sell
6,798
-20
-0.3% -$4.3K 0.63% 49
2022
Q1
$1.71M Sell
6,818
-75
-1% -$18.8K 0.83% 33
2021
Q4
$1.77M Sell
6,893
-50
-0.7% -$12.2K 0.84% 33
2021
Q3
$1.69M Sell
6,943
-150
-2% -$36.7K 0.91% 31
2021
Q2
$1.47M Sell
7,093
-400
-5% -$81.5K 0.82% 35
2021
Q1
$1.41M Sell
7,493
-500
-6% -$88.2K 0.87% 37
2020
Q4
$1.31M Hold
7,993
0.96% 37
2020
Q3
$997K Sell
7,993
-50
-0.6% -$6.19K 0.87% 42
2020
Q2
$781K Hold
8,043
0.75% 52
2020
Q1
$723K Sell
8,043
-187
-2% -$24.2K 0.82% 49
2019
Q4
$1.22M Sell
8,230
-90
-1% -$12.1K 0.96% 42
2019
Q3
$1M Sell
8,320
-100
-1% -$12.9K 0.89% 45
2019
Q2
$1.14M Sell
8,420
-125
-1% -$15.8K 1.03% 35
2019
Q1
$1.11M Buy
8,545
+575
+7% +$77.2K 1.06% 32
2018
Q4
$992K Sell
7,970
-280
-3% -$37.6K 1.03% 31
2018
Q3
$1.15M Buy
8,250
+405
+5% +$50.4K 0.98% 30
2018
Q2
$805K Buy
7,845
+105
+1% +$10.6K 0.71% 49
2018
Q1
$751K Buy
7,740
+125
+2% +$12.1K 0.65% 53
2017
Q4
$669K Buy
+7,615
New +$612K 0.59% 53

Other funds holding HCA

Kendall Capital Management's HCA Position: Q1 2026 in Review

Kendall Capital Management reduced its HCA Healthcare (HCA) stake by 5.1% in Q1 2026, selling an estimated $101K and leaving 3,710 shares worth $1.76M. The position accounts for 0.36% of the portfolio, ranked #72.

Kendall Capital Management first reported a position in HCA in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.89M in Q3 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Kendall Capital Management held 3,710 shares of HCA Healthcare worth $1.76M as of Q1 2026.
  • Kendall Capital Management sold 200 HCA Healthcare shares in Q1 2026, an estimated $101K.
  • HCA Healthcare made up 0.36% of Kendall Capital Management's portfolio in Q1 2026, its #72 holding.
  • Kendall Capital Management first reported a position in HCA Healthcare in Q4 2017 and has held it in 34 quarters since.
  • Kendall Capital Management's HCA Healthcare position peaked at $1.89M in Q3 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.